Brendan O'Grady

Chief Executive, Assertio Holdings

Appears in 1 story

Last updated Jun 16, 2026

Stories

Zydus buys its way into U.S. specialty drugs

Money Moves

As of June 2026: Sold the company after a competitive auction

Zydus, one of India's largest drugmakers, now owns a U.S. cancer-care drug. On June 16, 2026, it finished buying Assertio Holdings for $23.50 a share in cash, a deal worth about $166 million.

Updated Jun 16